An examination of the database strain SC5314 sequence has identified 28 putative ABC transporters 21 . Six CDR1, CDR2, CDR99, CDR3, CDR4, SNQ1 have the hallmark dual nucleotide binding domains NBD each followed by transmembrane domains TMD consisting of six transmembrane spans 11 Fig. 1 . Four of these genes CDR1-4 have been functionally analysed, but only CDR1 and CDR2 have been demonstrated to be involved in efflux of azole drugs. Disruption of CDR1 makes C. albicans hypersusceptible to azoles 22 and we have demonstrated that controlled over-expression of Cdr1p in a C. albicans CDR1-null mutant conferred resistance to FLC and other xenobiotics 23 . Although there is strong evidence for the involvement of Cdr1p in FLC resistance, RT-PCR evidence suggests that Cdr2p may also play a significant role 20 . Furthermore, we recently found that elevated expression of both Cdr1p and Cdr2p polypeptides in cell plasma membrane fractions also accompanied decreased susceptibility to azoles in sequential Candida albicans clinical isolates that developed FLC resistance Holmes et al. unpublished data . Therefore, an understanding of the mechanism of action of these two transporters could help develop new approaches to reducing antifungal treatment failure. Although many studies reviewed by Ernst et al. 24 have focussed on the mechanisms involved in the development and regulation of elevated pump expression, primary sequence changes within an ORF also affect the expression and function of proteins. This brief review will describe how changes in single residues within ABC transporters can influence functions such as substrate recognition and inhibitor susceptibilities.
ABC transporters Cdr1p and Cdr2p: functional studies
ABC transporter proteins are located in the plasma membrane, or in organelle membranes, of organisms as diverse as Escherichia coli and humans. They are ATP-dependent translocators of a wide variety of small molecules, including many xenobiotics, and typically comprise alternating pairs of cytoplasmic NBDs and membraneembedded TMDs that contain six transmembrane spans 25 . ABC transporters are important in many human genetic disorders 25 27 . In cancer patients, multidrug resistance MDR of neoplastic tissues can be a major obstacle in cancer chemotherapy, and the predominant cause of MDR is the over-expression and drug transport activity of P-glycoprotein P-gp 28 . The orientation of the four domains in ABC transporters varies in different organisms, depending on the functions performed by the pump 29, 30 . All NBD regions contain conserved motifs: Walker A and Walker B also found in other nucleotide-binding proteins and the familydefining C-loop or ABC signature motif LSGGQ . Saccharomyces cerevisiae Pdr5p is the archetype of the fungal pleiotropic drug resistance PDR family of drug transporters; the largest grouping 10 members among the 30 ABC transporters in this yeast 31 . C. albicans Cdr1p and Cdr2p show approximately 70% homology with Pdr5p.
In order to study the function of individual fungal transporters, researchers, including the authors, have used heterologous expression in the genetically tractable model yeast S. cerevisiae 32 35 . The host S. cerevisiae strain AD1-8u -has been developed to contain a mutant transcriptional regulator Pdr1-3p which leads to constitutive expression of genes integrated at the PDR5 locus. This gives high-level expression of functional heterologous proteins in the plasma membrane of S. cerevisiae 33, 36 . Seven of the endogenous efflux pump genes have been disrupted in this strain, so that the pump function measured is dominated by the introduced heterologous gene. We have demonstrated that we can use this system to clone and functionally express the individual alleles of C. albicans CaCdr1p 33 and other ABC and MFS transporters 37 . An analysis of plasma membrane fractions of S. cerevisiae cells hyper-expressing Pdr5p or individual alleles of Cdr1p or Cdr2p from laboratory strain ATCC 10261 revealed that these proteins were expressed at levels equivalent to 25-29% of membrane protein Fig. 2 . Heterologous expression of the efflux pump proteins allows direct functional comparison of pumps and identification of factors that affect function. A number of assays both whole cell and in vitro have been developed to assess the function of individual pump proteins. The simplest approach is to determine the inhibitory concentrations of antifungals on whole cells, using a liquid media-based minimal inhibitory concentration MIC microdilution assay such as that used in clinical laboratories 38 or a solid media drug diffusion 33 or drug dilution 39 resistance assay. A more direct measure of pump function is the quantification of substrate efflux using a radiolabelled substrate or a naturally fluorescent substrate such as rhodamine 6G R6G 33 . Fig. 3 shows the glucose-dependent R6G efflux from S. cerevisiae strains expressing either CaCdr1p or CaCdr2p, that had been preloaded with R6G under glucose-deprived conditions. Strains expressing either ATCC 10261 CaCdr1p allele achieved greater efflux than strains expressing either CaCdr2p allele, but this required higher glucose concentrations. Under the same conditions, no R6G efflux by the empty transformation cassette control strain AD/pABC3 was detected. There are also a number of assays to measure the function of the pump in purified membrane preparations reviewed by 24 such as the measurement of vandate-and oligomycin-sensitive ATPase activity 40 .
Identifying amino acid residues important for efflux pump function
Many studies have highlighted the importance of single residues in substrate recognition and inhibitor susceptibilities of pump proteins 24 . Human ABC transporters have been subjected to directed mutational analysis, and mapping of natural mutations, in order to elucidate structure/ function relationships reviewed by Frelet and Klein 41 . More than 50 single nucleotide polymorphisms SNPs have been reported for human P-gp, many of which affect the function of the protein 27, 42 . In fungal ABC transporters, a commonly conserved lysine in the Walker A motif is replaced by cysteine and in C. albicans Cdr1p NBD1 C193 was shown to be essential for ATPase activity 43, 44 . The C. albicans NBD2 has the conventional lysine residue at a similar position, which is also critical for function 45 . Site-directed mutation has shown that F774 in TM segment 6 of Cdr1p affects the protein's trafficking and localisation 46 . A T1351F mutation in the TM segment 11 of Cdr1p 35 and mutations in the TM-10 of S. cerevisiae Pdr5p 47 affect substrate specificity. Alanine scanning mutagenesis has identified single amino acid residues in Cdr1p TM-11 affecting function 34 and cysteine-scanning mutagenesis of human Pgp identified important residues for substrate binding in the TM-12 region of this pump protein 48 . Comparison of the primary structures of different ABC transporters can also provide important clues about the function and regulation of the fungal transporters. Although the fungal and human NBDs probably evolved by gene duplication from half sized transporters, fungal ABC transporters contain NBDs that appear less homologous and functionally less similar than their human counterparts. For example the Walker A, Walker B and signature motifs of the P-gp ATP binding site are highly conserved between its two NBDs. In contrast, the fungal signature motifs differ markedly between NBDs 43, 49 . Examination of these differences has provided further insight into structure/ function relationships. Mutational analysis of the two NBDs of C. albicans Cdr1p revealed that they influence Cdr1p function differently 45 . In the C. glabrata Cdr1p NBD1, a Walker A motif C189A mutation diminished enzyme activity by 30-40% without significantly increasing susceptibility to FLC or the fluorescent substrate R6G, whereas the comparable mutation in the Walker A motif of NBD2 K899A eliminated ATPase activity and dramatically increased susceptibility to xenobiotic pump substrates Tanabe et al. unpublished data .
Mapping of naturally occurring non-synonymous NS -SNPs that affect function has been applied widely to the identification of key amino acid residues in human ABC transporters 41 . We recently discovered that there is considerable heterozygosity in the CDR2 gene of C. albicans isolates up to 20 NS-SNPs that results in functional variation between the two alleles Holmes et al. unpublished data . The CDR1 gene of C. albicans laboratory strain ATCC 10261 showed less extensive heterozygosity, but also contains six NS-SNPs that result in functional differences between the allele proteins, as determined by separately cloning and hyperexpressing each allele denoted A or B in S. cerevisiae AD1-8u - Fig. 4 . In order to investigate the effect of introducing additional NS-SNPs, CDR1 was amplified under low fidelity conditions. Following cloning and transformation of S. cerevisiae AD1-8u -with the mutated DNA fragment, a strain with reduced fluconazole MIC 30 g/ ml was isolated. Sequencing showed that this strain contained the A allele with 3 additional non-synonymous SNPs. Each individual mutation was inserted into the A allele by sitedirected mutagenesis using recombinant PCR. Mutated Cdr1ps were expressed to a similar extent as the parental Cdr1pA Fig. 5 . Only mutation L1021S obtained in strain A'' showed reduced function, as demonstrated by a decreased FLC MIC, reduced glucose-dependent R6G efflux and lower ATPase activity, relative to the wild-type A allele. The L1021S mutation is immediately before the Walker B motif LLFLDE of NBD2 confirming that the NBD2 of C. albicans Cdr1p is critical for function, as previously reported 45 .
In conclusion, recent studies have made valuable progress in the determination of structure/function relationships for the primary sequences of the Cdr pump proteins of C. albicans. Such studies are important as reference points, linking structural analysis to function. Combined use of data from mutational analysis and crystallography will provide the best opportunities to define the mode of action of lead inhibitors and for mapping the essential features of substrate and inhibitor binding sites.
